THE OB-C GROUP, LLC for EMERGENT BIOSOLUTIONS INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Homeland Security HOM
HR307 and S242: Pandemic and All-Hazards Preparedness Reauthorization Act of 2013; entire bill reauthorizing funding and strengthening bioterrorism preparedness programs, including Biomedical Advanced Research & Development Authority (BARDA) and the development of medical countermeasures (MCMs).
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL S JOHNSON | — |
| THOMAS J KEATING | — |
| ROBERT H MARSH | — |
| NATHAN J MILLER | — |
| PATRICIA A NELSON | — |
| LAWRENCE F O'BRIEN, III | — |
| ROBERT G STEVENSON | — |
Budget/Appropriations BUD
HR933-Consolidated and Further Continuing Appropriations Act, 2013, provisions related to development, acquisition and stockpiling of biodefense vaccines; Draft Fiscal Year 2014 Department of Homeland Security appropriations bill - same issues as previously stated; Draft Fiscal Year 2014 Department of Health and Human Services and Education, and related agencies appropriations bill - same issues as previously stated.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL S JOHNSON | — |
| THOMAS J KEATING | — |
| ROBERT H MARSH | — |
| NATHAN J MILLER | — |
| PATRICIA A NELSON | — |
| LAWRENCE F O'BRIEN, III | — |
| ROBERT G STEVENSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.